Back to top

Image: Bigstock

Surging Earnings Estimates Signal Good News for OraSure (OSUR)

Read MoreHide Full Article

OraSure Technologies, Inc. (OSUR - Free Report) develops, manufactures, markets, and sells oral fluid diagnostic products that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on OSUR’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that OraSure could be a solid choice for investors.

Current Quarter Estimates for OSUR

In the past 30 days, two estimates have gone higher for OraSure while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing from 3 cents a share 30 days ago, to 17 cents today, a significant move.

Current Year Estimates for OSUR

Meanwhile, OraSure’s current year figures are also looking quite promising, with two estimates moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, increasing from 20 cents per share 30 days ago to 36 cents per share today, an increase of 80%.

Bottom Line

The stock has also started to move higher lately, adding 27.3% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank stocks here.

Just Released – Driverless Cars: Your Roadmap to Mega-Profits Today

In this latest Special Report, Zacks’ Aggressive Growth Strategist Brian Bolan explores a full-blown technological breakthrough in the making – autonomous cars. He also spotlights 8 stocks with tremendous gain potential to feed off this phenomenon. Click to see the stocks right now >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


OraSure Technologies, Inc. (OSUR) - free report >>

Published in